Kenneth Hsiang
Hello. I am Ken Hsiang, the Head of Investor Relations for ASE Technology Holdings. Welcome to our Third Quarter 2021 Earnings Release. Thank you for attending our earnings presentation today. Please refer to the safe harbor notice on Page 2. All participants consent to having their voices and questions broadcast via participation in this event. If participants do not consent, please disconnect at this time. I would like to remind everyone that the presentation that follows may contain forward-looking statements. These forward-looking statements are subject to a high degree of risk, and our actual results may differ materially. For the purposes of this presentation, our dollar figures are generally stated in new Taiwan dollars, unless otherwise indicated. As a Taiwan based company, our financials are presented in accordance with Taiwan IFRS. Results presented using Taiwan IFRS may differ materially from results using other accounting standards, including those presented by our subsidiary using Chinese GAAP. I'm joined today by our CFO, Joseph Tung. For today's presentation, I will make the prepared remarks going over our financial results. And Joseph will be available to answer questions during the Q&A. During the quarter, ASE saw new historical highs in its revenues and profits led by strength within our ATM business. Despite electronic industry challenges with various supply chain shortages, the overall health of our businesses remain relatively strong. During the third quarter, our ATM factory lines remained highly utilized through the entire quarter despite some device order volatility. Supply chain security still appears to be of primary importance to our customers. Even as certain parts of the supply chain appear to be improving in health, various shortages such as wafers and substrates continue to persist. Meanwhile, some of our capital equipment installations for the current season have been completed. And while it's true, lead times on some equipment have come in, but others remain in short supply. Our EMS business also completed the quarter with strong year-over-year growth in revenues despite finishing the quarter slightly behind our own expectations. Our EMS factories still faced significant challenges related to component shortages and supply chain issues disrupting and product manufacturing. Things continue to be sticky with the various manufacturing limitations, making EMS factories run less smoothly. With that said, let's go over the numbers for the quarter. Please turn to Page 3, where you will find our third quarter consolidated results. Intercompany transactions between our ATM and EMS businesses have been eliminated during consolidation. For the third quarter, we recorded fully diluted EPS of $3.20 and basic EPS of $3.29. Year-to-date, fully diluted and basic EPS is now $7.43 and $7.66, respectively. Consolidated net revenue increased by 19% quarter-over-quarter and by 22% year-over-year. The sequential increase was primarily driven by growth within both our ATM and EMS businesses. We had a gross profit of $30.8 billion with a gross margin of 20.4%. Our gross margin improved by 0.9 percentage points sequentially and by 4.4 percentage points year-over-year. Our gross margin improvement is primarily driven by margin improvement in our ATM business, offset in part by higher EMS business mix. Our operating expenses increased by $0.8 billion sequentially and $1.8 billion annually to $12.4 billion. Our operating expense percentage declined 1 percentage points sequentially and 0.4 percentage points year-over-year to 8.2%. For the full year, we continue to see an improvement from last year's 9% level. Operating profit was $18.4 billion, up 40% sequentially and 102% year-over-year. Operating margin increased 1.8 percentage points sequentially and 4.8 percentage points year-over-year to 12.2%. During the quarter, our nonoperating income was 0 and contains $0.6 billion of net interest expense, offset entirely by gains related to our foreign exchange hedging activities, investments and asset sales. Tax expense for the quarter was $3.6 billion. The effective tax rate for the third quarter was 20%, slightly lower than our expectation. As a result of increased profitability, we were able to offset the recognition of our annual undistributed earnings tax with higher recognition of deferred tax assets during the quarter. Going forward, we continue to believe our ongoing effective tax rate to be about 20%. Net income for the quarter was $14.2 billion, representing an increase of $3.9 billion sequentially and an improvement of $7.5 billion year-over-year. From a foreign exchange perspective, NT dollar per U.S. dollar exchange rate was at 27.8% during the third quarter of 2021, TWD28 during the second quarter of 2021 and TWD29.5 during the third quarter of 2020. We approximate that NT dollar appreciation had a negative 0.3 percentage point impact sequentially and a negative 1.7 percentage point impact year-over-year to both gross and operating margins at the holding company level. On the bottom of the page, we provide key P&L line items without the inclusion of PPA-related expenses. Consolidated gross profit, excluding PPA expenses, would be $31.7 billion with a 21.1% gross margin. Operating profit would be $19.6 billion with an operating margin of 13%. Net profit would be $15.4 billion with a net margin of 10.2%. Basic EPS, excluding PPA expenses, would be $3.56. On Page 4 is our ATM P&L. It is worth noting here that the ATM revenue reported here contains revenue eliminated at the holding company level related to intercompany transactions between our ATM and EMS businesses. Business grew rapidly during the quarter. A strong seasonal uptick in advanced packaging led the way, driven by applications in the computing and communications end markets. Utilization rates across our key equipment were full or near full. For the third quarter of 2021, revenues for our ATM business were $90.1 billion, up $11.1 billion from the previous quarter and up $18.3 billion from the same period last year. This represents a 14.1% increase sequentially and a 25.4% increase year-over-year. On a U.S. dollar basis, our ATM revenues grew by 15% sequentially, which is slightly ahead of our own expectations. Gross profits for our ATM business was $24.7 billion, up $4.5 billion sequentially and $10.2 billion year-over-year. Gross profit margin for our ATM business was 27.4%, up 1.8 percentage points sequentially and 7.2 percentage points year-over-year. Our sequential gross margin improvement was primarily due to higher loading, offset in part by a higher raw material product mix and ForEx impact. The year-over-year gross margin improvement was primarily the result of higher loading, improved efficiency and a friendlier ASP environment, offset somewhat by NT dollar appreciation. During the third quarter, operating expenses were $9.1 billion, up $0.7 billion sequentially and $1.4 billion year-over-year. The sequential and annual operating expense increases were primarily driven by higher employee bonuses, which are based on a profit-sharing model. Our operating expense percentage continued to decline to 10.1%, down 0.5 percentage points sequentially and down 0.7 percentage points year-over-year. During the third quarter, operating profit was $15.6 billion, representing an improvement of $3.8 billion quarter-over-quarter and an improvement of $8.8 billion year-over-year. Operating margin was 17.3%, improving 2.3 percentage points sequentially and 7.8 percentage points year-over-year. From a foreign exchange perspective, we approximate that NT dollar appreciation had a negative 0.4 percentage point impact sequentially and a negative 2.5 percentage point impact year-over-year to both gross and operating margins at the holding company level. Without the impact of PPA-related depreciation and amortization, ATM gross profit margin would be 28.4% and operating profit margin would be 18.6%. On Page 5, you'll find a graphical representation of our ATM P&L. ATM revenue for the quarter represents an all-time high. We believe that the current year's strength has been generated by strong demand across all product lines, including various trailing edge wirebond-based capacities, a revival in use and a reset in terms of profitability and wirebonded product lines have helped boost business for us during 2021. Going forward, we believe that wire-bonded products will continue to grow along with our advanced packaging product lines. From an application of technology perspective, we increasingly see more opportunities for our ATM technologies to proliferate into subsystem and system level manufacturing. These products serve as a growing market created by increased transistor cosies at leading-edge nodes and expanding consumer appetites for smaller, more elegant electronic solutions. We increasingly provide cost-effective manufacturing solutions that make visionary products viable. On Page 6 is our ATM revenue by market segment. You can see here a pickup in our communications and computing market segments with a decline in automotive, consumer and other products. On an absolute revenue perspective, all segments grew. A particular interest is that our automotive business grew 68% on a year-over-year basis. We believe that the automotive market segment will be a significant contributor to our own growth during the coming year. On Page 7, you will find our ATM revenue by service type. As we mentioned last quarter, our advanced packaging business picked up in accordance with our expectations, increasing 3 percentage points becoming 36% of our ATM revenues. Wirebonding as a percentage of revenue came down 3 percentage points. But on an absolute dollar basis, wirebond revenue grew 7% sequentially. On Page 8, you can see the results of our EMS business and a graphical representation of our EMS revenue by application. The information we provide in regards to our EMS business may differ materially from the information directly provided by our subsidiary as they report independently using Chinese GAAP. The overall environment at the EMS level has been sticky. Mass production continues to be choppy. Component shortages and supply chain deviations made their impacts felt during the quarter. And when we look at the entire situation, we believe we have been adversely impacted by various upstream component shortages and downstream manufacturing issues. This resulted in manufacturing delays for multiple devices and customers. This is why our third quarter EMS revenues came in slightly behind our expectations. Fortunately, we do believe that most of the impacted revenue will get pushed out into later quarters, but overall manufacturing throughput continues to be choppy, limiting production efficiency. During the third quarter, EMS revenues increased by 24% sequentially and 15% year-over-year. Our EMS gross profit was $5.9 billion, increasing $1.4 billion sequentially and $0.8 billion year-over-year. The sequential EMS gross profit increase was the result of the seasonal build. The year-over-year gross profit increase was the result of a higher volume business. Gross profit margin for our EMS business unit came in at 9.6%, which is an improvement of 0.5 percentage points sequentially and a decline of 0.1 percentage points year-over-year. The sequential improvement is primarily the result of cost differences from differing product mix and better utilization. On a year-over-year basis, there is a slight decline in gross margin due to new facility ramp-up costs. Our EMS business unit's third quarter operating expenses were $3.2 billion, flat sequentially, while increasing $0.4 billion year-over-year. Annual operating expenses are up primarily as a result of a larger operating base. Our operating expense percentage declined 1.2 percentage points sequentially to 5.3%, while staying flat year-over-year. The sequential operating expense percentage decline was primarily driven by flat operating costs with higher revenues. Our EMS operating profit improved $1.4 billion sequentially and $0.3 billion year-over-year. Our EMS operating margin was 4.3%, improving 1.7 percentage points sequentially and declining 0.1 percentage points year-over-year. The overall difficult manufacturing environment continues to persist. We were able to exceed our targeted 4% operating margin in the third quarter, and likely will in the fourth quarter. However, for the full year, we believe that we will be unable to reach our EMS operating margin target of 4%. We believe that the operating margin variance is generally attributable to IC shortages and the COVID-19 operating environment. We expect some improvement in the operating environment next year. And as such, we believe a 4% operating margin target continues to be applicable for future years. On the bottom half of the page, you will find a graphical representation of our EMS revenue by application. Consumer product revenues as a percentage of total increased 5 percentage points, in line with its seasonality, while our Industrial segment came down 4 percentage points. On Page 9, you will find key line items from our balance sheet. Total unused credit lines amounted to $261.5 billion. After payment of our dividend in the third quarter, our net debt-to-equity ratio temporarily increased to 71%. On Page 10, you'll find our equipment capital expenditures. Amounts on this slide are denoted in U.S. dollars. Machinery and equipment capital expenditures for the third quarter totaled $468 million, of which $294 million were used in packaging, $101 million in testing, $60 million in EMS operations and $13 million in interconnect materials and others. And at this time, we see a slight uptick in our capital expenditures now up 25% from last year. This pickup in expected capital spending relates to additional opportunities in advanced packaging and test business generated by our turnkey strategy. Financially speaking, our equipment capital expenditures expand factory capacity and utilization of that factory capacity generates EBITDA. Each equipment capital investment scales out facilities to generate additional revenue and EBITDA. This chart represents the ongoing EBITDA generating capability of the company. EBITDA for the most recent 4 quarters was USD 3.9 billion, significantly ahead of our CapEx even in a high CapEx time frame. USD 3.9 billion of EBITDA, state in another way, represents TWD25.8 of EBITDA per share. As of the end of the third quarter, capital equipment availability for certain product lines appear to be normalizing. However, this situation was not across the board for us. There are still extended lead times for certain pieces of capital equipment. For many product lines, we are still running capacity constraint and still in need of capacity expansion. We have noticed, especially recently that much is being made about the timing of our capital equipment decisions. We understand this, from a simplified perspective, may serve as a predictive indicator, but this indicator can easily be misinterpreted as it means different things during different times of the season and in different contexts. Spending on capital equipment fundamentally indicates that we believe there is an additional production capacity needed for sustained new business. But what does our capital expenditures leveling off during a record year mean? And here is where some of the confusion seems to exist. It means that, for this season, after a period of rapid expansion, factory capacity is finally aligned with near-term expansion needs and goals. We have historically had the luxury of being able to judge our capital expenditures with a relatively short lead time, meaning we traditionally finalize our equipment orders about 3 to 6 months ahead of delivery. This allows for a final level of precision and granularity as well as better alignment with incoming business. Because of these short lead times and the annual seasonality of electronics, this intersection of capacity and expansion goals happens every single year. In fact, this intersection is actually happening substantially later in the year than in previous years. Our wirebonding CapEx leveling off this late in the manufacturing season actually means there was strong demand this year, and capacity took a long time to catch up. In short, we are having a really good year. What it doesn't mean from our perspective is that a near-term correction is coming. Quite to the contrary, we still see growth in our business next year. We usually do not make detailed comments on next year's outlook this early. But given the level of volatility driven by what would seem to be a focus on noise versus the actual signal, we feel it prudent to express a more extensive view. We are, again, put into a position much like we were last year at this time in which the company's outlook signaled strength amongst generally cautious sentiment. The overall manufacturing environment remains positive for us. But admittedly, some of the data is a bit difficult to interpret. And while we do not presume to have the definitive answer on the semiconductor cycle, we do wish to express that we continue to have strong order flow from the vast majority of our customers with orders extending well into 2022 and some as far out as 2023, well beyond normal booking times. From a more macro perspective, our data points taken along with the understanding that global wafer supply remains in severe shortage. This shortage is at a grand scale, causing design products unable to find manufacturing slots across the semiconductor manufacturing supply chain. Products with high promise relating to 5G, AI, IoT and ADAS are being delayed, if not outright being canceled in this environment. Despite noise of double booking, product and end market softness, we believe there still exists substantial pent-up demand. Barring a significant industry-wide correction, we expect whatever future slack in wafer demand to be quickly taken up by other customers and products looking for production slots during this shortage environment. As such, we believe it's reasonable to continue to expect a somewhat full and linearized delivery pattern of wafers, leaving relatively little room for seasonal softness. With that said, we expect our own manufacturing linearization to continue, resulting in a better-than-seasonal first quarter outlook and extending into healthy but moderated growth during 2022. This seems to be in line with much of the industry. We would like to defer to Dr. Wu's year-end presentation for more detail. But given this macro environment, we see full year sales and earnings growth based upon simple annualization of our recent quarter's results. And using that same logic, we expect full year margins should also continue to expand. This is all before we even consider new high-end wafer capacity entering the system, efficiency gains, market share gains and additional outsourcing from IDMs. From a pricing perspective, even though we may not see as many expedite fees this coming year, we believe the ASP environment will continue to be friendly. Pulling things back to the fourth quarter immediately in front of us, we expect for our product lines to remain loaded with business most likely staying steady. There are potential issues with substrate and downstream shortages, but we do believe things are manageable at this point. With that, we would like to provide our fourth quarter business outlook as follows: In U.S. dollar terms, our ATM fourth quarter 2021 business level should be similar to our third quarter 2021 business level. Our ATM fourth quarter 2021 gross margin should be similar to our third quarter 2021 gross margin. For our EMS business in U.S. dollar terms, our EMS fourth quarter 2021 business level should come close to our fourth quarter 2020 levels. Our EMS fourth quarter 2021 operating margin should come close to our third quarter 2021 operating margin. This concludes our prepared remarks. I'd like to open the floor for Q&A. If you have a question, please raise your hand in the WebEx interface in front of you. Thank you.